Topcare Ultra Strength Antacid Assorted Berry

Description

TopCare® health Ultra Strength Antacid Tablets are formulated to provide relief from upset stomach, heartburn, and acid indigestion. Each tablet contains 1000 mg of calcium carbonate as the active ingredient. The product is available in assorted berry flavors and is packaged in a bottle containing 72 chewable tablets. The National Drug Code (NDC) for this product is 76162-130-68, and it is designed to compare to TUMS®.

Uses and Indications

This drug is indicated for the relief of acid indigestion, heartburn, and upset stomach.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over are instructed to chew 2 to 3 tablets as symptoms occur, or as directed by a healthcare professional. It is recommended that the tablets be chewed thoroughly before swallowing to ensure optimal absorption and efficacy.

Contraindications

Use of this product is contraindicated in patients who exceed a dosage of 7 tablets within a 24-hour period. Additionally, the maximum dosage should not be utilized for more than 2 weeks unless under the guidance and supervision of a healthcare professional. This limitation is in place to mitigate the risk of potential adverse effects associated with prolonged or excessive use.

Warnings and Precautions

There are currently no specific warnings or general precautions associated with the use of this product. Healthcare professionals are advised to remain vigilant and consider the individual patient's health status and medical history when prescribing.

In the absence of defined laboratory tests, it is recommended that healthcare providers utilize standard monitoring parameters relevant to the patient's condition to ensure safe use. Regular assessments may be necessary to evaluate the patient's response to treatment and to identify any potential adverse effects.

In the event of any concerning symptoms or adverse reactions, healthcare professionals should instruct patients to seek immediate medical assistance. Additionally, if a patient experiences any unexpected or severe side effects, they should be advised to discontinue use and contact their healthcare provider promptly for further evaluation and guidance.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. While specific serious adverse reactions are not detailed, it is important to note that interactions may occur with other medications.

In particular, patients currently taking prescription drugs should exercise caution, as antacids may interact with certain prescription medications. This interaction could potentially alter the effectiveness of the prescribed treatment or lead to unexpected side effects.

Healthcare providers should be consulted to ensure safe and effective use of this medication, especially in the context of concurrent therapies. Monitoring for any unusual symptoms or changes in health status is advised, and patients should report any concerns to their healthcare professional promptly.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Healthcare professionals should consider advising patients to space the administration of antacids and other medications to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Topcare Ultra Strength Antacid Assorted Berry (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may chew 2-3 tablets as symptoms occur, or as directed by a healthcare professional. It is important to keep this medication out of reach of younger children to ensure safety.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and supportive care remain the cornerstone of managing overdose situations until the patient stabilizes or further interventions are deemed necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients not to exceed a maximum of 7 tablets within a 24-hour period. Additionally, patients should be informed that the maximum dosage of this product should not be used for more than 2 weeks unless directed by a healthcare professional.

It is also important for healthcare providers to encourage patients to consult with a doctor or pharmacist prior to use if they are currently taking any prescription medications. Patients should be made aware that antacids may interact with certain prescription drugs, and this interaction could affect the efficacy of their treatment.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature to ensure optimal conditions. Healthcare professionals are advised not to use the product if the printed seal under the cap is torn or missing, as this may indicate a compromise in the product's safety or efficacy.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients to consult a doctor or pharmacist prior to use if they are currently taking a prescription drug, as antacids may interact with certain medications. Additionally, patients who are pregnant or breastfeeding should seek guidance from a healthcare professional before using the product.

Drug Information (PDF)

This file contains official product information for Topcare Ultra Strength Antacid Assorted Berry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)